NGNE neurogene.com: Operating Profitability

neurogene.com (NGNE) - corporate logo

Neurogene Inc. (NGNE) minimizes the risk of clinical failures through the variability of its gene therapy programs for neurological pathologies. The operating profit margin clearly demonstrates the financial dynamics, where the current level is approximately 0.00. However, geopolitical tensions complicate the cross-border logistics of biomaterials, while the implementation of robotic laboratories significantly accelerates the screening of therapeutic vectors.

NGNE: Neurogene Inc Operating Sales Margin 02/21/2024 - 11/19/2026

Analytical breakdowns for Neurogene Inc. (NGNE)

- share price and consensus valuation forecast:
Analysis of all company metrics:NGNE, Neurogene Inc.
Core merchandise of Neurogene Therapeutics

Inelastic demand for genetic brain defect therapies provides Neurogene Inc. (NGNE) with exceptional market influence. Analyzing operational efficiency levels, the investor assesses the ability of the EXACT platform to convert revenue into earnings before interest and taxes. This ratio measures the portion of operating income in every dollar earned. An increase in this metric confirms cost optimization. A stable margin minimizes the asset's default risks.

Competing companies

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Annexon Biosciences Inc. - Operating Profit Rate|OMER (Omeros Corp) - Operating Margin|ACIU: Operating Profit Rate|Operating Sales Margin VYGR (Voyager Corp)|Operating Sales Margin Neumora NMRA|Operating Profitability Scilex Holding Company, Inc. SCLX|Operating Profitability Margin Tevogen Bio Inc.|ACOG - Operating Profitability|Operating Profitability Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Operating Sales Margin|Cassava Sciences Inc (SAVA) - Operating Margin|Operating Sales Margin ASRT|Operating Margin coyatherapeutics.com|Operating Margin VTGN|Ovid Therapeutics - Return on Sales by Operating Profit|Operating Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Operating Sales Margin|ATHE - Operating Profitability|Profitability of Operations clene.com CLNN|PEPG: Operating Margin|Return on Sales by Operating Profit JUNS|RLMD (Relmada Corp) - Operating Margin|Annovis Bio Inc (ANVS) - Profitability of Operations|Operating Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operating Profit Rate|Operating Profitability Klotho Neurosciences KLTO|NRSN: Return on Sales by Operating Profit|RVPH: Operating Sales Margin|MTVA: Operating Profitability|NRXS (NeurAxis Inc) - Operating Sales Margin|Operating Sales Margin Helius Medical Technologies, Inc.|Operating Profitability Passage Bio Inc.|Operating Return on Sales bionomics.com.au NEUP|Operating Margin NERV|Operating Margin Athira Pharma Inc (ATHA)|Operating Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Return on Sales by Operating Profit|CYCN - Operating Profitability|Operating Return on Sales Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Operating Sales Margin|Operating Profitability Margin Cortigent, Inc. CRGT|Operating Profitability Avenue Therapeutics, Inc.|Operating Sales Margin BrainStorm Cell Therapeutics Inc. (BCLI)|Operating Profitability Cara Therapeutics, Inc (CARA)|Operating Profitability CHRO (Chromocell Therapeutics Corp.)|Operating Margin ELYM (eliemtx.com)|intracellulartherapies.com - Operating Profitability|LBPH: Operating Sales Margin|Operating Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin